Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.

Van Maerken, Tom, Ferdinande, Liesbeth, Taildeman, Jasmien, Lambertz, Irina, Yigit, Nurten, Vercruysse, Liesbeth, Rihani, Ali, Michaelis, Martin, Cinatl, Jindrich, Cuvelier, Claude A, and others. (2009) Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. Journal of the National Cancer Institute, 101 (22). pp. 1562-74. ISSN 1460-2105. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:34071)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.

Abstract

Nutlin-3 activates the p53 pathway and suppresses tumor growth in this model system of chemoresistant neuroblastoma, provided that wild-type p53 is present.

Item Type:	Article
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Divisions > Division of Natural Sciences > Biosciences
Depositing User:	Martin Michaelis
Date Deposited:	05 Jun 2013 19:25 UTC
Last Modified:	16 Nov 2021 10:11 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/34071 (The current URI for this page, for reference purposes)

University of Kent Author Information

Michaelis, Martin.

Creator's ORCID:	https://orcid.org/0000-0002-5710-5888
CReDIT Contributor Roles:

Depositors only (login required):

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.